1
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
Condition(s):Severe Haemophilia ALast Updated:February 23, 2018Completed
Hemophilia A: 745 Clinical Trials, Page 1 of 75
Hide Studies Not Open or Pending
2
An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
Condition(s):Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor; Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor; Haemophilia ALast Updated:December 21, 2020Recruiting
3
A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A
Condition(s):Hemophilia ALast Updated:September 23, 2020Recruiting
4
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
Condition(s):Hemophilia ALast Updated:March 27, 2019Completed
5
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:October 23, 2017Completed
6
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
Condition(s):Hemophilia ALast Updated:April 7, 2020Recruiting
7
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
Condition(s):Hemophilia ALast Updated:December 24, 2020Recruiting
8
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
Condition(s):Hemophilia A; Factor VIIILast Updated:December 30, 2020Not yet recruiting
9
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Condition(s):Hemophilia ALast Updated:July 16, 2018Completed
10
Evaluation of Long-term Safety of ADYNOVI/ADYNOVATE (Antihaemophilic Factor [Recombinant] PEGylated, Rurioctocog Alfa Pegol) in Patients With Haemophilia A – An ADYNOVI/ADYNOVATE Post-Authorisation Safety Study (PASS)
Condition(s):Hemophilia ALast Updated:September 4, 2020Recruiting